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Metabolis:m of RadiocaesiuDl during
Gestation and Lactation as in:ßuenced
by Ferric-cyanoferrate(lI)
IT HAS been shown that oral administration of ferric-
cyanoferrate(II) (FOF) leads to a .diminished
enteral reabsorption of radiocaesium and, thus, to
a rnarked reduction of the body burden.(l-6) The
present study is concerned with the effect of FOF in
rats during gestation and lactation.
The animals of the first group were injected intra-
peritoneally with carrier-free 1370S01 two days prior
to mating, those of. the second group immediately
after parturition. Unmated rats served as control.
One halfofeach·group was maintained on a standard
diet, the other one on pellets with 1 per cent FOF.
The retention of 1370S was assayed during 3 weeks
after the injection by means of a whole-body counter.
In all experimental groups, the dependence of
1370s-retention upon time is given by the sum of two
exponentials: R t = a1 exp (-~t) + a2 exp (-)'2t),
5'Vhere Ät amounts to .....,0·7. The following conclu-
sions can be drawn from the data compiled in the
table:
Group FCF al a2 A.2
(1) unmated 24 76 0·0633
(2) ullmated + 50 50 0·116
(3) gestation 26 74 0·0775
(4) gestation + 46 54 0·134
(5) lactation 44 56 0·124
(6) lactation + 68 32 0·183
(i) FOF is. highly effective in decreasing the
fraction as wen as the half-tirne of the second term
of the retention function.
(ii) The excretion of 137Cs is enhanced during
gestation (in addition to the rnarked placental trans-
fer) and, in particular, during lactation.
(iii) The comparison between the accumulation
0[1370 s in the Htters and the "apparent" cumulative
excretion with milk (as calculated from the data 01
the Table) shows that the diminished retention in
lactating rats is only partly due to the excretion with
milk. Rather a generally enhanced turnover has to
be assumed.
(iv) There is a complete additivity between the
effect of FCFand that of gestation and lactation,
respectively.
A more detailed description and discussion of the
experiments are given elsewherd7) .
Institut für Strahlenbiologie F. HAVI,.JCEK
Kernforschungszentrum Karlsruhe,
Germany
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INTERACTION BETWEEN CHELATES AND ENDOGENOUS ZINC
A. CATSCH, A.-E. HARMUTH-HoENE, F. HAVLlCEK and S. CARPY
Repeated administration of the Ca-chelates of EDTA, DTPA and related compounds can
give rise to taxie side-effects, mainly to nephrotic lesions. The most straightforward and
likely explanation suggests an interaction between the chelating agent and essential trace
metals, i.e. a disturbance of metal homeostasis which leads to an impairment of the activity of
metal-controIIedbiological entities and functions. Which metal(s) and which biological
constituents are actuaIIy involved, however, is an open question. AIthough the Ca-ehelates
lead to a marked zincuria, whereas the exeretion of other trace metals is infl.uenced, if at aII, to
a lesser degree (Bohne et al., 1967a; Candura et al., 1960; MilIar et al., 1954; Perry and Perry,
1959; Spencer and Rosoff, 1966; Tarui, 1960; Truhaut et al., 1966), the pathogenetic rele-
vance of these findings, however, is not yet fuIIy understood. Our experimental contribution
is eoneerned with same quantitative aspects of the interaction between chelating agents and
endogenaus Zn.
In the first experimental series, rats were injected with carrier"free 65Zn and after different
time intervals (from the 7th until the 28th day) with the Ca-ehelates of EDTA and DTPA.
The dosage was 1, 10 and 100 ,limol per animal, respeetively. TheoretieaIIy one ought to
expect a dependenceof the excretion of stable Zn and 65Zn on the value of the so-caIIed
eonditional stability constant E (cf. Catsch, 1964a). E ean be derived from the stability of the
Zn-chelate and the dasage of the ehelate; it also takes into aecount the competition of
endogenaus H+ and Ca2 +. Starting fram this basis, we have to expect a 100-times higher
effectiveness of DTPA. The plot of the urinary stableZn against E (Fig. 1) shows that this is
aetuaIIy the ease; with the only exception that 1 ,limol DTPAis markedly less effective than the
equivalent dose of 100 ,limol EDTA. The same holds also for the urinary excretion of 65Zn. As
ean be seen in Fig. 2, its specifie aetivity in urine depends upon the time of ehelate admin-
istration and decreases with a half-time of 11 days.
The enehanced urinary excretion of Zn and 65Zn does not necessariIy imply a genuine
removal of endogenaus Zn. The possibility has to be considered that the chelators exert an
infl.uenee solelyon the excretion route and that the higher urinary levels are compensated by a
eorrespondingly lower faeeal elimination.
In order to answer this question, the foIIowing experiment was performed: 65Zn was
injected and the urinary and faecal exeretions of 65Zn on the tenth day were determined in
untreated animaIs, as weIl as after administration of 1 and 100 ,limol BDTA and DTPA
respeetively. By subtraeting the contral values from the excretion rates as infl.uenced by the
ehelates, we obtain an estimate ofthe Zn-balane.e. Fig. 3 shows that the net excretion of
65Zn iSdistinetIy enhanced in spite ofthe somewhat lower faeeal excretion. Since there are no
eogent reasons to assurne that the specific aetivities of 65Zn excreted with the urine and into
the intestine are not identical, one may eoncIude that we are dealing with a genuine mobiIiza-
tion of endogenaus Zn. Onee more, the exceptionaI behaviour of 1 ,limol DTPA has to be
stressed.
The question is raised as to the source of the surplus excreted Zn. We ean take it for
granted that the phY8iological dilution space of the chelate ions i8 mainly eonfined to ex-
tracellular water (Foreman, 1960). The Zn-content of this compartment, however, in the rat
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amounts to 0.15 ,umol only (Gilbert and Taylor, 1956) and is, thus, distinctly lower than the
amount that can be r~movedby chelators. It has been shown by Bohne et al. (1967b) that DTPA
does not affect the absorption of Zn from the gut. Consequently, fhe assumption that an
enhanced enteral absorption accounts for the elevated excret10n can be ruled out and we
may conclude that the excreted Zn is partly supplied by the intracellular fraction of the Zn-
pool. This conjecture is in keeping with the concept that the exchange of Zn between the
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Fig. 1. Dependence of the urinary Zn-excretion (24 hrs.) upon the conditional
stability constant E. Fiduciallimits for p. .05.
Fig.2. Dependence of the specific activity of the urine upon the time of chelate
administration.
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The statement that the chelating agents, by disturbing this equilibrium, are able to mobilize
intracellular Zn can be made more precise: it can be assumed that the specific activities of the
removed and the removable Zn are identical and, hence, decrease with identical half-tirnes.
The half-time of urinary 65Zn amounts to 11 days (Fig. 2). The retention equations compiled
by Ballou and Thompson (1961) show that for the pertinent time interval and for all organs,
blood plasma ineluded, terms with half-times > 23 days are dominating. The only exception is
the liver with a short-lived fraction (nine days). This elose agreement justifies the tentative
assumption that the chelates lead to a partial depletion of the Zn-stores of the liver.
Let us now turn to the exceptional behaviour of the 1 ,umol DTPA-dosage. The starting
point for its understanding is given by the fact that the co-ordination number of Znz+ is 4,
whereas DTPA is an octadentate ligand so that the relatively stable bimetallic species Znz-
DTPA can be formed (Anderegg et al., 1959). In contrast ta the simple 1: l-chelate, Znz-
DTPA has one negative charge only and it is, therefore,conceivable that it may penetrate
cellular membranes more easily than the uninuclear species. Having entered the intracellular
space of the liver, the bimetallic chelate would show a changed excretion pattern: partIy it i8
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excreted via the biliary route, partly - following rediffusion into the blood - by the kidneys.
This assumption is consistent with Qur experimental results (Fig. 3). In order to explain why
the net excretion of 65Zn is sti11lower than one should anticipate on the basis of the E-value,
two (experimentally substantiated) prerequisites have to be fulfilled: (a) that the specific
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Fig. 3. Dependence of the llrinary and fecal 65Zn-excretion (percentage of 65Zn-dose) upon
the conditional stability constant E.
activity of the intracellular space is lower than that of the extracellular fraction (Gilbert and
Taylor, 1956) and (b) that isotopic exchange between the endogenous Zn and the Zn chelated
by the ligand takes place (Catsch and Le, 1965, 1966).
The formation of bimetallic chelates needs one essential prerequisite: the concentratiQn of
the ligand should not be largely in excess of the metal concentration, as otherwise simple
1 : 1-chelates would be formed preferably. Since the removable endogenous Zn-fraction is
limited, we have to deduce that this condition is fulfilled only in the case of the 1 ,umol-dose.
It is self-evident why EDTAdoes not exhibit an anomalous behaviour. EDTA possesses 6
ligand atoms only and is, therefore, unable to form bimetallic chelates of appreciable
stability.
A new parameter was incorporated in the next experiment. Three days prior to the deter-
mination of the DTPA-efficacy (in removing Zn and 6SZn) the rats were pre-treated with 100
,umol DTPA per day. As can be seen from Table I, the pre-tr~atment does not affect the
effectiveness of the test-dose. Apparently, the Zn-depletion of the organism is transient only
and the depleted Zn-stores are quicklYTefi11edwith enterally absorbedZn (Bohne eta!., 1967b).
If one considers these results in conjunction with the finding that the effectiveness of DTPA
in removing Zn is 100 times that ofEDTA while the relative potency ofDTPA withrespect to
chronic toxicity equates 2 only (Catsch, 1964b), it is quite obvious that one cannot simply
equate toxicity with general Zn-depletion. On the other hand, we cannot overlook the fact
that Zn- and Co(II)-chelates are definitely less toxic than Ca-chelates (Catsch, 1964b; Catsch
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and Von Wedelstaedt, 1965). This fact throws serious doubts on attempts to' make the che-
late ion per se responsible for the toxieity and to interpret the renal lesions as a so-called
osmotic nephrosis. .
Investigations of the in vitro inaetivation of the.Zn-eontaining carbonie anhydrase show
that the degree of in.aetivation (although it defu;l1tely is brought about by removal of Zn) does
TABLE I
Urinary excretionfollowing the administration of100 p.mol DTPA
on the 14th day
Pre-treatment on 11th-13th Zn,
day (100 p.mol nTPA per day) (p,g)
86.7 ±4.9
+ 82.3 ±4.0
65Zn
(percent of dose)
0.97 ± 0.05
1.04±0.02
not correlate with the Zn-stability constants. Furthermore, the mobilization ofZn is preceded
by the formation of ternary complexes. In this ease only a few of the electron-donoratoms of
the chelating agent are involved and one cannot operate with the usual stability eonstants
which are valid for the 1: 1-chelates. We do not want to assert that the inactivation of renal
.carbonic anhydrase is a deeisive factor in the development of nephrotoxicity. On the con-
trary, this particular enzyme is most definitelynot involved. The findings 0 btained with carbonie
anhydrase, however, could serve as a model in explaining the missing correlation between the
toxicity of chelators and their affinity toward Zn and - we want to stress this point -' to other
traee metals as weIl.
In the chrome treatment situation the therapeutie index of Zn-DTPA is 10-20 times higher
than that of Ca-DTPA (Catseh et al., 1964; Catsch and Von WedeIstaedt, 1965). A final re-
eommendation of Zn-DTPA, however, cannot be made until we know whether the retention
of 65Zn following the administration of Zn-DTPA (labelled with 65Zn) 1s due to a genuine
splitting off of Zn andfor to isotopie exchange with endogenous Zn. This question is erucial
TABLE TI
JJrineipleef the method using65Ztl~DTPA~lrC
Znexch - exchangeable fraction of the endogenous Zn-pool
Zntat - total dose of administered Zn
Znret retained ffaction
Znmab - mobilized fraction
65Zn/Zn
Zn/I4C
Injected
solution
Urine
(1) ZnexCh =Zntot (SI/Ur-I)
(2) Znret/mab = Zntot (1- U2/S2)
positive figures of 2: retention of Zn
negative figures of 2: mobilization of Zn
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beeause of possible long-term side-effeets of Zn. To answer this question, we seleeted a
method (Harmuth-Hoene et al., 1966) whieh uses Zn-DTPA doubly labelled with 65Zn and
14C. The underlying prineiple as weIl as the results are given in Tables II and UI. Firstly,
splitting-off and retention of Zn have to be excluded. On the eontrary, Zn-DTPA is eapable
of binding and, thus, mobilizing a seeond Zn-Ion. Seeondly, these data rully eonfirm our
.: . . .... 6
TABLEIII
Exchange, mobilization and retention 0/ Zn /ollowing administra-
tion o.f.Zn-DTPA. Lower and upper fiducial limits /or P . 0.05
(For /urther explanation see Table II)
.umol Zn-DTPA
Znexch (.umol)
Znret/mob (.urno!)
0.53;
-0.22;
1
0.62
-0.42
10
0.31; 1.16
-1.13; 0.58
earlier assumption that in the ease of 1 ,urnol DTPA the exehangeable fraetion ofthe Zn-pool
shows a signifieantly higher value; onee more, a dependenee of the metabolie pathway and
the physiologieal dilution spaee upon ehelate dosage is suggested.
In summarizing the results of Table IU, we have no misgivings regarding the therapeutie
use of Zn-DTPA in humans.
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DISCUSSION
LINDENBAUM: Dr. Catsch, did you measure the aetivity of the earbonie anhydrase in the liver?
CATSCH: Only in the kidneys, and we have done it in viva and in vitra. We have to use a very
high eoneentration (about 10- 2 molar), in order to get an inaetivation of the earbonic
anhydraseby approximately 10 %.
LINDENBAUM: And also, your point about the toxicity ratios for the EDTA and DTPA
calcium and zine ehelates: they may not neeessarily have anything to do with one another.
CATSCH: You eannot overlook the fact that DTPA is a hundred times more effeetive in
removing zine than EDTA, whereas its toxicity is only twiee higher.
LINDENBAUM: They may be two separate things. 1t is interesting to eonsider.
CATSCH: You should expeet a eorrelation between the two figures.
SMITH: Doctor Catseh, when you refer to treatments using the zine salt, I presume you do
not suggest its use in the acute or prompt treatment ease but reeommend zine-DTPA
mainly fOT treatments in delayed long-term therapy?
CATSCH: I think zinc-DTPA should not be given in acute emergencies, but in our opinion it is
the eompound of choice in a ehronie treatment situation. This means treatment for about
two, three weeks, or even longer periods.
